Clinician's Roundtable

Host: Mark Nolan Hill, MD Guest: Michael Oxman, MD Guest: William Schaffner, MD A vaccine for adult shingles was approved by the FDA in 2006 and is in use today. Perversely, recent data shows that delivery of the adult Shingles vaccine has been a challenge. This includes delivery to older populations, on whom the Shingles virus typically realizes its greatest impact. With Baby Boomers nearing the age of greatest risk, how can physicians and other medical professionals improve their dialogue with patients about this vaccine? Host Dr. Mark Nolan Hill examines strategies to improve immunization rates for adult Shingles with Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine at Vanderbilt University School of Medicine.

Host: Mark Nolan Hill, MD Guest: Michael Oxman, MD Guest: William Schaffner, MD A vaccine for adult Shingles was approved in 2006 by the FDA and is in use today. Yet delivery of this vaccination has not been as widespread as it could and should be. With this in mind, many hospitals and clinics are working to improve on their current approach to its distribution; at some health centers, this includes allowing pharmacists to administer the vaccine. Can this program be implemented nationwide, in accordance with local and state laws? Would this program necessitate any change in insurance coverage for providers? Learn more from Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine at Vanderbilt University School of Medicine. Will this program also lower overall immunization costs? Dr. Mark Nolan Hill hosts.

Host: Mark Nolan Hill, MD Guest: Michael Oxman, MD Guest: William Schaffner, MD A vaccine for adult Shingles was officially licensed for use in 2006, but recent data shows that delivery of this vaccination has been a challenge. What are some of the issues which are limiting the distribution of the Shingles vaccine? How can we best address these difficulties? For expert insight on these questions and more, host Dr. Mark Nolan Hill welcomes Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine and professor of medicine in the department of infectious diseases at Vanderbilt University School of Medicine.

Host: Mark Nolan Hill, MD Guest: Michael Oxman, MD Guest: William Schaffner, MD Decades of research have gone into the isolation and refinement of a vaccine for adult shingles, approved in 2006 by the FDA and in use today. Do we now fully understand the mechanism which activates the latent varicella-zoster virus, leading to adult shingles? How did initial isolation, going back more than 30 years, of the vaccine for chicken pox (triggered by the same varicella virus) contribute to the investigations on adult shingles? Host Dr. Mark Nolan Hill discusses these questions and more with Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine and professor of medicine in the department of infectious diseases at Vanderbilt University School of Medicine.

Host: Bruce Bloom, DDS, JD Guest: Anthony Fiore, MD Why has this year's flu season seemed more severe than those in the past? Are the vaccines working? Are influenza strains more difficult to predict? In addressing this year's peculiar flu season, host Dr. Bruce Bloom speaks with Dr. Tony Fiore, a vaccination and immunization expert from the CDC's National Center for Infectious and Respiratory Diseases in Atlanta.

Host: Bruce Bloom, DDS, JD Guest: Anthony Fiore, MD With this year's flu season comes the recommendation from the CDC to extend the age of childhood vaccination past the previous age of 59 months, to 18 years. Why the change, and what are the recommendations based upon? Joining Dr. Bruce Bloom to discuss this year's recommendation is Dr. Anthony Fiore, a vaccination and immunization expert, and medical epidemiologist from the CDC in Atlanta.

Host: Shira Johnson, MD Guest: Michael Franzblau, MD Dr Michael Franzblau is interviewed by Dr Shira Johnson to discuss medical ethics and the role of the physician in war and in peace. Tune in to this stimulating discussion with a noted ethicist to hear his views on the role of the physician in euthanasia, lethal injection and in pre-war Germany and Japan.

Host: Shira Johnson, MD Guest: Michael Franzblau, MD Dr Michael Franzblau is interviewed by Dr Shira Johnson to discuss the ethical compromises and conflicted roles of the physician at Tiergarten 4 in Hilter's Germany.

Host: Leslie P. Lundt, MD Guest: Michael Lardon, MD Our guest today specializes in helping elite athletes enhance their performance. What can we learn from these Olympic and PGA athletes and from the psychiatrist who helps them train? Host Dr. Leslie Lundt welcomes Dr. Michael Lardon to discuss his work in performance enhancement.

Host: Leslie P. Lundt, MD Guest: Michael Lardon, MD Why do some athletes consistently seem to perform under pressure? Think Tiger Woods, Michael Jordan and Lance Armstrong. Is there science to support their seemingly superhuman ability to get in the zone? Sports medicine expert Michael Lardon, MD joins host Dr. Leslie Lundt to discuss his research into “the zone”.